Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men
Hermann M. Behre(University Hospital in Halle), Doug Colvard(Contraception Research and Development), David J. Handelsman(Anzac Research Institute), Silvia Werdhy Lestari(University of Indonesia), Michael Zitzmann(University Hospital Münster), Ndema Habib(World Health Organization), Frederick C. W. Wu(Manchester Royal Infirmary), Maria Cristina Meriggiola(Azienda USL di Bologna), Gabriela Noé(Instituto Chileno de Medicina Reproductiva), Kirsten M. Vogelsong(World Health Organization), Kim Linton(Contraception Research and Development), Robert I. McLachlan(Hudson Institute of Medical Research), Marianne M. Callahan(Contraception Research and Development), Richard A. Anderson(University of Wisconsin Carbone Cancer Center), M. M. Misro(National Institute of Health and Family Welfare), Mario Festin(Khon Kaen University)
Cited by 139
Related Papers
World Health Organization reference values for human semen characteristics*‡
|Human Reproduction Update|2009|2.8k
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2018|1.6k
Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men
|New England Journal of Medicine|2010|1.5k
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Investigation, treatment and monitoring of late-onset hypogonadism in males
|European Journal of Endocrinology|2008|855